IDiyas

For the Inventor, By the Inventor

River Vale, NJ, United States of America

Rolf Paul

USPTO Granted Patents = 13

Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 109(Granted Patents)


Company Filing History:

goldMedal12 out of 3,580 
 
American Cyanamid Company
 patents
silverMedal1 out of 832,680 
Other
 patents

Years Active: 1978-1997

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5639887 - MDR reversal agents (1997-06-17),
2. 5561141 - MDR reversal agents (1996-10-01),
3. 5550149 - MDR reversal agents (1996-08-27),
4. 5387685 - MDR reversal agents (1995-02-07),
5. 5162328 - N-[3-[2-(1H-imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine (1992-11-10),
6. 4579848 - 5-substituted[1,2,4]triazolo[1,5-c]pyrimidin-2-amines (1986-04-01),
7. 4447603 - Substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4-(3H)-ones (1984-05-08),
8. 4124766 - Substituted 3-(4-imidazolylmethylene)carbazic and thiocarbazic acid (1978-11-07),
9. 4115572 - Imidazo-[1,5-d]-as-triazin-1(2H)-ones and method of ameliorating asthma (1978-09-19),
10. 4107309 - Substituted imidazo[1,2-d]-as-triazines (1978-08-15),
11. 4107308 - Imidazo[1,5-d]-as-triazines (1978-08-15),
12. 4107307 - Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones (1978-08-15),
13. 4096257 - Substituted imidazo [1,2-d]-as-triazines (1978-06-20),

Title: Rolf Paul: Innovator in Chemotherapeutic Advancements

Introduction

Rolf Paul is a notable inventor based in River Vale, NJ, with a significant contribution to the field of chemotherapeutic agents. He holds 13 patents, showcasing his dedication to innovation and improvement in medical treatments. His work primarily focuses on developing compounds that enhance the effectiveness of anti-cancer therapies.

Latest Patents

Rolf Paul's latest patents include MDR reversal agents, which consist of compounds of a specific general formula. These compounds are designed to potentiate the activity of chemotherapeutic anti-cancer agents by increasing the sensitivity of multi-drug resistant cells to such treatments. The compounds feature a straight or branched (C2-C12) alkyl or a phenyl moiety, which plays a crucial role in their effectiveness.

Career Highlights

Throughout his career, Rolf Paul has worked with prominent organizations, including the American Cyanamid Company. His experience in these companies has allowed him to refine his skills and contribute significantly to the field of pharmaceuticals.

Collaborations

Rolf has collaborated with several professionals in his field, including Judith Menschik and Dennis W. Powell. These collaborations have likely enriched his work and led to innovative solutions in cancer treatment.

Conclusion

Rolf Paul is a distinguished inventor whose work in developing MDR reversal agents has the potential to transform cancer treatment. His contributions to the field are invaluable, and his patents reflect a commitment to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…